OpenURL Connection Search

Select item for more details and to access through your institution.

Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer.
Published in:
Breast Cancer Research & Treatment, 2024, v. 207, n. 3, p. 551, doi. 10.1007/s10549-024-07386-8
By:
- François, Chloé;
- Mailliez, Audrey;
- Chretien, Sebastian;
- Leguillette, Clémence;
- Oudoux, Aurore;
- Ceugnart, Luc;
- Barthoulot, Maël;
- Cougnenc, Olivier;
- Olivier, Anaïs
Publication type:
Article
Efficacy and safety of 153Sm-EDTMP as treatment of painful bone metastasis: a large single-center study.
Published in:
2018
By:
- Kolesnikov-Gauthier, Hélène;
- Lemoine, Nathalie;
- Tresch-Bruneel, Emmanuelle;
- Olivier, Anaïs;
- Oudoux, Aurore;
- Penel, Nicolas
Publication type:
journal article
HIGH-DOSE 131I-MIBG THERAPIES IN CHILDREN: FEASIBILITY, PATIENT DOSIMETRY AND RADIATION EXPOSURE TO WORKERS AND FAMILY CAREGIVERS.
Published in:
Radiation Protection Dosimetry, 2017, v. 173, n. 4, p. 395, doi. 10.1093/rpd/ncw030
By:
- Cougnenc, Olivier;
- Defachelles, Anne-Sophie;
- Carpentier, Philippe;
- Lervat, Cyril;
- Clisant, Stéphanie;
- Oudoux, Aurore;
- Kolesnikov-Gauthier, Hélène
Publication type:
Article
Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 12, p. 4590, doi. 10.1210/jc.2007-0938
By:
- Oudoux, Aurore;
- Salaun, Pierre-Yves;
- Bournaud, Claire;
- Campion, Loïc;
- Ansquer, Catherine;
- Rousseau, Caroline;
- Bardet, Stéphane;
- Borson-Chazot, Françoise;
- Vuillez, Jean-Philippe;
- Murat, Arnaud;
- Mirallié, Eric;
- Barbet, Jacques;
- Goldenberg, David M.;
- Chatal, Jean-François;
- Kraeber-Bodéré, Françoise
Publication type:
Article
Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 7, p. 1270, doi. 10.1007/s00259-010-1417-1
By:
- Pallardy, Amandine;
- Bodet-Milin, Caroline;
- Oudoux, Aurore;
- Campion, Loïc;
- Bourbouloux, Emmanuelle;
- Sagan, Christine;
- Ansquer, Catherine;
- Testard, Aude;
- Resche, Isabelle;
- Bridji, Boumédiène;
- Kraeber-Bodéré, Françoise;
- Rousseau, Caroline
Publication type:
Article
99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 3, p. 637, doi. 10.1007/s00259-007-0625-9
By:
- Carlier, Thomas;
- Oudoux, Aurore;
- Mirallié, Eric;
- Seret, Alain;
- Daumy, Isabelle;
- Leux, Christophe;
- Bodet-Milin, Caroline;
- Kraeber-Bodéré, Françoise;
- Ansquer, Catherine
Publication type:
Article
FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease.
Published in:
Annals of Hematology, 2006, v. 85, n. 11, p. 759, doi. 10.1007/s00277-006-0151-z
By:
- Querellou, Solène;
- Valette, Frédéric;
- Bodet-Milin, Caroline;
- Oudoux, Aurore;
- Carlier, Thomas;
- Harousseau, Jean-Luc;
- Chatal, Jean-François;
- Couturier, Olivier
Publication type:
Article
Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.
Published in:
Journal of Nuclear Medicine, 2018, v. 59, n. 3, p. 502, doi. 10.2967/jnumed.117.195883
By:
- Yanik, Gregory A.;
- Parisi, Marguerite T.;
- Naranjo, Arlene;
- Nadel, Helen;
- Gelfand, Michael J.;
- Park, Julie R.;
- Ladenstein, Ruth L.;
- Poetschger, Ulrike;
- Boubaker, Ariane;
- Valteau-Couanet, Dominique;
- Lambert, Bieke;
- Castellani, Maria-Rita;
- Bar-Sever, Zvi;
- Oudoux, Aurore;
- Kaminska, Anna;
- Kreissman, Susan G.;
- Shulkin, Barry L.;
- Matthay, Katherine K.
Publication type:
Article
Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement.
Published in:
Journal of Nuclear Medicine, 2012, v. 53, n. 8, p. 1185, doi. 10.2967/jnumed.111.101865
By:
- Salaun, Pierre-Yves;
- Campion, Loïc;
- Bournaud, Claire;
- Faivre-Chauvet, Alain;
- Vuillez, Jean-Philippe;
- Taieb, David;
- Ansquer, Catherine;
- Rousseau, Caroline;
- Borson-Chazot, Françoise;
- Bardet, Stéphane;
- Oudoux, Aurore;
- Cariou, Bertrand;
- Mirallié, Eric;
- Chien-Hsing Chang;
- Sharkey, Robert M.;
- Goldenberg, David M.;
- Chatal, Jean-François;
- Barbet, Jacques;
- Kraeber-Bodéré, Françoise
Publication type:
Article
Phase II study of 131I‐metaiodobenzylguanidine with 5 days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP.
Published in:
Pediatric Blood & Cancer, 2023, v. 70, n. 11, p. 1, doi. 10.1002/pbc.30615
By:
- Sevrin, François;
- Kolesnikov‐Gauthier, Hélène;
- Cougnenc, Olivier;
- Bogart, Emilie;
- Schleiermacher, Gudrun;
- Courbon, Frederic;
- Gambart, Marion;
- Giraudet, Anne‐Laure;
- Corradini, Nadège;
- Badel, Jean‐Noël;
- Rault, Erwann;
- Oudoux, Aurore;
- Deley, Marie Cécile Le;
- Valteau‐Couanet, Dominique;
- Defachelles, Anne‐Sophie
Publication type:
Article
Pretargeted Radioimmunotherapy in Rapidly Progressing, Metastatic, Medullary Thyroid Cancer.
Published in:
Cancer (0008543X), 2010, v. 116, p. 1118
By:
- Kraeber-Bodéré, Francoise;
- Salaun, Pierre-Yves;
- Oudoux, Aurore;
- Goldenberg, David M.;
- Chatal, Jean-Francois;
- Barbet, Jacques
Publication type:
Article
Toxicity and Efficacy of Combined Radioimmunotherapy and Bevacizumab in a Mouse Model of Medullary Thyroid Carcinoma.
Published in:
Cancer (0008543X), 2010, v. 116, p. 1053
By:
- Salaun, Pierre-Yves;
- Bodet-Milin, Caroline;
- Frampas, Eric;
- Oudoux, Aurore;
- Sal-Maurel, Catherine;
- Faivre-Chauvet, Alain;
- Barbet, Jacques;
- Paris, Francois;
- Kraeber-Bodéré, Françoise
Publication type:
Article
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 2, p. 292, doi. 10.1007/s00259-017-3829-7
By:
- Ladenstein, Ruth;
- Lambert, Bieke;
- Pötschger, Ulrike;
- Castellani, Maria-Rita;
- Lewington, Valerie;
- Bar-Sever, Zvi;
- Oudoux, Aurore;
- Śliwińska, Anna;
- Taborska, Katerina;
- Biassoni, Lorenzo;
- Yanik, Gregory A.;
- Naranjo, Arlene;
- Parisi, Marguerite T.;
- Shulkin, Barry L.;
- Nadel, Helen;
- Gelfand, Michael J.;
- Matthay, Katherine K.;
- Park, Julie R.;
- Kreissman, Susan G.;
- Valteau-Couanet, Dominique
Publication type:
Article

Found: 13

Therapeutic impact of <sup>18</sup>F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer.

Efficacy and safety of <sup>153</sup>Sm-EDTMP as treatment of painful bone metastasis: a large single-center study.

HIGH-DOSE <sup>131</sup>I-MIBG THERAPIES IN CHILDREN: FEASIBILITY, PATIENT DOSIMETRY AND RADIATION EXPOSURE TO WORKERS AND FAMILY CAREGIVERS.

Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy.

Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.

<sup>99m</sup>Tc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography.

FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease.

Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.

Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement.

Phase II study of <sup>131</sup>I‐metaiodobenzylguanidine with 5 days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP.

Pretargeted Radioimmunotherapy in Rapidly Progressing, Metastatic, Medullary Thyroid Cancer.

Toxicity and Efficacy of Combined Radioimmunotherapy and Bevacizumab in a Mouse Model of Medullary Thyroid Carcinoma.

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.